With unique sample preparation processes, hematology analyzers assist in the diagnosis of various diseases, such as infections, anemia, viruses, diabetes, genetic problems, and cancer. According to the recent Persistence Market Research report, some of the key users of the global hematology analyzer & reagent market include clinical testing laboratories, hospitals, and research institutions. Based on the type of automation, two types of hematology analyzer include fully automated hematology analyzers and semi-automated analyzers.
Due to the regions’ high disposable income and increasing adoption of automated hematology instruments by diagnostics laboratories, North America currently dominates the global hematology analyzer & reagent market, followed by Europe. Asia is expected to be the fastest growing market in the next five years due to the developing healthcare infrastructure and increasing funding towards the development of hematology products in this region. Rising awareness about better healthcare and a large patient population base are also factors that promote the growth of the market in Asia.
Some of the key factors driving the growth of the market in general are:
- Increasing adoption of automated hematology instruments
- Rising technological advancements
- Integration of basic flow-cytometry techniques in modern hematology analyzers
- Rising demand for high-throughput hematology analyzers and
- Development of high-sensitivity point-of-care (POC) hematology testing
However, the high cost of hematology analyzers, intense competition among existing players, stringent and time-consuming regulatory policies for hematology instruments are restraining the growth of the global market.
Certain factors that could open up opportunities for new players in the market include usage of microfluidics technology in hematology analyzers, introduction of digital imaging system in hematology laboratories and increasing focus toward emerging markets, such as India and China.
Moreover, safety and quality of hematology analyzer could be a challenge for the growth of the market. Increasing instances of partnership among hematology instruments and consumables manufacturers is one of the recent trends in the market.
Major companies operating in the market include Sysmex Corporation, Abbott Laboratories, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Mindray Medical International Limited, Siemens Healthcare, HORIBA, Ltd. and NIHON KOHDEN CORPORATION.